Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Obstructive Lung Diseases

Free Subscription 13.05.2024 1 Allergy 4 Am J Respir Crit Care Med 4 Ann Allergy Asthma Immunol 5 Arch Bronconeumol 1 BMC Pediatr 1 BMJ 4 Chest 1 Clin Exp Allergy 2 J Allergy Clin Immunol 1 J Appl Physiol (1985) 3 J Asthma 1 J Investig Allergol Clin Immunol 1 Pediatr Allergy Immunol 2 Pediatr Pulmonol 1 Respir Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. RANJBAR M, Whetstone CE, Cusack RP, Al-Sajee D, et al
   Comparison of upper and lower airway expression of SARS-COV-2 receptors in allergic asthma.
   Allergy. 2024 May 10. doi: 10.1111/all.16157.
   PubMed        
   
   

   
   Am J Respir Crit Care Med

2. BURGEL PR, Bush A
   Reversal of Bronchiectasis in Children: Early Intervention May Stop the Vicious Circle!
   Am J Respir Crit Care Med. 2024 May 8. doi: 10.1164/rccm.202404-0764.
   PubMed        
   
   
3. HORANI A
   Deciphering Idiopathic Bronchiectasis One Gene at a Time.
   Am J Respir Crit Care Med. 2024 May 8. doi: 10.1164/rccm.202403-0611.
   PubMed        
   
   
4. GAO Y, Richardson H, Dicker AJ, Barton A, et al
   Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study.
   Am J Respir Crit Care Med. 2024 May 8. doi: 10.1164/rccm.202310-1729.
   PubMed         Abstract available
   
   
5. MCSHANE PJ, Brunton AE, Choate R, Marmor M, et al
   The Impact of Tobacco Smoking in Bronchiectasis: Data from the United States Bronchiectasis and NTM Research Registry.
   Am J Respir Crit Care Med. 2024 May 7. doi: 10.1164/rccm.202402-0466.
   PubMed        
   
   

   
   Ann Allergy Asthma Immunol

6. KLOEPFER KM, Kennedy JL
   Decoding viral infections and risk for asthma: Biomarkers or clinical histories?
   Ann Allergy Asthma Immunol. 2024;132:553-554.
   PubMed        
   
   
7. KATIAL RK, Hoyte FCL
   Comment on geographic variation in disease burden among patients with severe persistent asthma in the United States.
   Ann Allergy Asthma Immunol. 2024;132:551-552.
   PubMed        
   
   
8. CHEN C, Song X, Murdock DJ, Marcus A, et al
   Association between allergic conditions and COVID-19 susceptibility and outcomes.
   Ann Allergy Asthma Immunol. 2024 Jan 17:S1081-1206(24)00011.
   PubMed         Abstract available
   
   
9. BEIGELMAN A, Goss CW, Wang J, Srinivasan M, et al
   Azithromycin therapy in infants hospitalized for respiratory syncytial virus bronchiolitis: Airway matrix metalloproteinase-9 levels and subsequent recurrent wheeze.
   Ann Allergy Asthma Immunol. 2024;132:623-629.
   PubMed         Abstract available
   
   

   
   Arch Bronconeumol

10. PAN CX, He ZF, Lin SZ, Yue JQ, et al
    Clinical Characteristics and Outcomes of the Phenotypes of COPD-Bronchiectasis Association.
    Arch Bronconeumol. 2024 Apr 23:S0300-2896(24)00110.
    PubMed         Abstract available
    
    
11. MASELLI DJ, Diaz AA
    Mortality Risk in Bronchiectasis.
    Arch Bronconeumol. 2024 Apr 24:S0300-2896(24)00114.
    PubMed        
    
    
12. BALLESTEROS-REVIRIEGO G, Arbillaga-Etxarri A, Marti JD
    Inspiratory Muscle Training: Back to Basics Must be the First Step?
    Arch Bronconeumol. 2024;60:267-268.
    PubMed        
    
    
13. PAPI A, Alfano F, Bigoni T, Mancini L, et al
    N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses.
    Arch Bronconeumol. 2024;60:269-278.
    PubMed         Abstract available
    
    
14. CUENCA PERIS S, Martinez Tomas R, Briones Gomez A, Cases Viedma E, et al
    What to Do When Endobronchial Volume Reduction Treatment Fails.
    Arch Bronconeumol. 2024;60:319-320.
    PubMed        
    
    

    
    BMC Pediatr

15. TIAN C, Xiong S, Li S, Song X, et al
    Impulse oscillometry in the diagnosis of cough variant asthma in children.
    BMC Pediatr. 2024;24:296.
    PubMed         Abstract available
    
    

    
    BMJ

16. IACOBUCCI G
    Montelukast: UK regulator says asthma drug needs clearer warnings of side effects.
    BMJ. 2024;385:q1048.
    PubMed        
    
    

    
    Chest

17. TAN DJ, van Geffen WH, Walters EH
    Impact of Triple Therapy vs Dual Bronchodilator Therapy on Mortality Rates in COPD.
    Chest. 2024;165:e158-e159.
    PubMed        
    
    
18. WU WW, Wang G
    How Much Do We Know About Clinical Response and Remission to Add-On Biologics in Severe Asthma in a Real-World Setting.
    Chest. 2024;165:e157-e158.
    PubMed        
    
    
19. JOHNSON KM, Duan KI
    The Growing Burden of COPD in the United States.
    Chest. 2024;165:1027-1028.
    PubMed        
    
    
20. MANNINO DM, Roberts MH, Mapel DW, Zhang Q, et al
    National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029.
    Chest. 2024;165:1093-1106.
    PubMed         Abstract available
    
    

    
    Clin Exp Allergy

21. HOWARD R, Fontanella S, Simpson A, Murray CS, et al
    Component-specific clusters for diagnosis and prediction of allergic airway diseases.
    Clin Exp Allergy. 2024;54:339-349.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

22. SAKANO Y, Sakano K, Hurrell BP, Helou DG, et al
    Blocking CD226 regulates type 2 innate lymphoid cell effector function and alleviates airway hyperreactivity.
    J Allergy Clin Immunol. 2024;153:1406-1422.
    PubMed         Abstract available
    
    
23. SHIN YH, Kim JH, Lee SH, Lee SY, et al
    Allergic rhinitis phenotypes with distinct transcriptome profiles in children: a birth cohort.
    J Allergy Clin Immunol. 2024 Jan 17:S0091-6749(24)00032.
    PubMed         Abstract available
    
    

    
    J Appl Physiol (1985)

24. VAMEGHESTAHBANATI M, Kingdom L, Hoffman EA, Kirby M, et al
    Airway tree caliber heterogeneity and airflow obstruction among older adults.
    J Appl Physiol (1985). 2024;136:1144-1156.
    PubMed         Abstract available
    
    

    
    J Asthma

25. KROLL H, Feinberg T, Soffer G, Reznik M, et al
    Concordance of Provider Chart Notation and Guideline-Based Classification of Asthma Severity.
    J Asthma. 2024 May 8:1-15. doi: 10.1080/02770903.2024.2353106.
    PubMed         Abstract available
    
    
26. SALERNI C, Baccelli A, Parazzini EM, Rinaldo R, et al
    A tailored approach to refractory severe Mepolizumab-associated headache: a case study.
    J Asthma. 2024;61:649-652.
    PubMed         Abstract available
    
    
27. SOLANKI N, Beck B, Labadia M, Smith K, et al
    The role of ACT score in mepolizumab discontinuation.
    J Asthma. 2024;61:550-560.
    PubMed         Abstract available
    
    

    
    J Investig Allergol Clin Immunol

28. TOMAS-PEREZ M, Trisan Alonso A, Montoro-Ferrer A, Dominguez-Ortega J, et al
    Concomitant Efficacy of Dupilumab in Treating Eosinophilic Esophagitis and Type 2 Asthma.
    J Investig Allergol Clin Immunol. 2024 May 9:0. doi: 10.18176/jiaci.1011.
    PubMed        
    
    

    
    Pediatr Allergy Immunol

29. WONG LSY, Akenroye A, Eigenmann P, Tham EH, et al
    Editorial comments on "Asthma and rhinitis control in adolescents and young adults: A real-world MASK-air study".
    Pediatr Allergy Immunol. 2024;35:e14134.
    PubMed        
    
    

    
    Pediatr Pulmonol

30. STEIMEL E, Bayer DK, Wright BA, Hinds DM, et al
    Little lungs, big relief: Dupilumab in a 2-year-old with severe persistent asthma.
    Pediatr Pulmonol. 2024 May 9. doi: 10.1002/ppul.27058.
    PubMed        
    
    
31. HA EK, Jin JO, Kim JH, Shin J, et al
    Age-related effects of Mycoplasma pneumoniae infection and subsequent asthma exacerbation in children.
    Pediatr Pulmonol. 2024 May 6. doi: 10.1002/ppul.26907.
    PubMed         Abstract available
    
    

    
    Respir Res

32. AU-DOUNG PLW, Chan JCH, Kui OYH, Ho MKY, et al
    Objective monitoring tools for improved management of childhood asthma.
    Respir Res. 2024;25:194.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.